The results of Dr. Raines' comparison of human IL-6 detection across multiple immunoassay platforms was presented at the Biomarker World Congress in Philadelphia, PA.
In addition to selecting the correct biomarker for clinical studies, it is also important to select the correct platform for measuring the biomarker so that it meets the needs of the study. Assay performance across various platforms was evaluated using commercial kits available for IL-6. The platforms evaluated include an ELISA kit, Aushon Ciraplex® ULTRA assay, MSD V-plex assay, and Erenna IL-6 Immunoassay. Results comparing the ability to detect endogenous IL-6 in serum, correlation between platforms, and other validation parameters will be discussed.
Learn more about our
NEW Ciraplex® ULTRA Assays
These ultrasensitive assays offer exceptional precision and reproducibility
with an extended dynamic range allowing for femtogram (fg/ml) levels of detection